• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白质代谢在癌症进展中的作用及其作为癌症治疗靶点的潜力。

Participation of protein metabolism in cancer progression and its potential targeting for the management of cancer.

机构信息

Department of Orthopedics, Affiliated Hospital of Changchun University of Traditional Chinese Medicine, Changchun, 130000, China.

Department of Thoracic Surgery, Affiliated Hospital of Changchun University of Traditional Chinese Medicine, Changchun, 130000, China.

出版信息

Amino Acids. 2023 Oct;55(10):1223-1246. doi: 10.1007/s00726-023-03316-y. Epub 2023 Aug 30.

DOI:10.1007/s00726-023-03316-y
PMID:37646877
Abstract

Cancer malignancies may broadly be described as heterogeneous disorders manifested by uncontrolled cellular growth/division and proliferation. Tumor cells utilize metabolic reprogramming to accomplish the upregulated nutritional requirements for sustaining their uncontrolled growth, proliferation, and survival. Metabolic reprogramming also called altered or dysregulated metabolism undergoes modification in normal metabolic pathways for anabolic precursor's generation that serves to continue biomass formation that sustains the growth, proliferation, and survival of carcinogenic cells under a nutrition-deprived microenvironment. A wide range of dysregulated/altered metabolic pathways encompassing different metabolic regulators have been described; however, the current review is focused to explain deeply the metabolic pathways modifications inducing upregulation of proteins/amino acids metabolism. The essential modification of various metabolic cycles with their consequent outcomes meanwhile explored promising therapeutic targets playing a pivotal role in metabolic regulation and is successfully employed for effective target-specific cancer treatment. The current review is aimed to understand the metabolic reprogramming of different proteins/amino acids involved in tumor progression along with potential therapeutic perspective elucidating targeted cancer therapy via these targets.

摘要

癌症恶性肿瘤可以广义地描述为表现为不受控制的细胞生长/分裂和增殖的异质性疾病。肿瘤细胞利用代谢重编程来满足维持其不受控制的生长、增殖和存活所需的上调营养需求。代谢重编程也称为代谢改变或失调,发生在正常代谢途径中,用于生成合成前体,以继续形成生物量,从而在营养缺乏的微环境下维持致癌细胞的生长、增殖和存活。已经描述了广泛的代谢失调/改变途径,包括不同的代谢调节剂;然而,本综述重点深入解释诱导蛋白质/氨基酸代谢上调的代谢途径修饰。同时探索了各种代谢循环的基本修饰及其随之而来的结果,这为代谢调节中的关键治疗靶点提供了有希望的治疗靶点,并成功地用于有效的靶向特异性癌症治疗。本综述旨在了解肿瘤进展中涉及的不同蛋白质/氨基酸的代谢重编程,并通过这些靶点阐明靶向癌症治疗的潜在治疗观点。

相似文献

1
Participation of protein metabolism in cancer progression and its potential targeting for the management of cancer.蛋白质代谢在癌症进展中的作用及其作为癌症治疗靶点的潜力。
Amino Acids. 2023 Oct;55(10):1223-1246. doi: 10.1007/s00726-023-03316-y. Epub 2023 Aug 30.
2
Progress in research on the role of amino acid metabolic reprogramming in tumour therapy: A review.氨基酸代谢重编程在肿瘤治疗中的作用研究进展:综述。
Biomed Pharmacother. 2022 Dec;156:113923. doi: 10.1016/j.biopha.2022.113923. Epub 2022 Oct 29.
3
The significant role of amino acid metabolic reprogramming in cancer.氨基酸代谢重编程在癌症中的重要作用。
Cell Commun Signal. 2024 Jul 29;22(1):380. doi: 10.1186/s12964-024-01760-1.
4
Perspectives of Reprogramming Breast Cancer Metabolism.重新编程乳腺癌代谢的观点。
Adv Exp Med Biol. 2017;1026:217-232. doi: 10.1007/978-981-10-6020-5_10.
5
Targeting Metabolism in Cancer Cells and the Tumour Microenvironment for Cancer Therapy.针对癌细胞和肿瘤微环境的代谢进行癌症治疗。
Molecules. 2020 Oct 20;25(20):4831. doi: 10.3390/molecules25204831.
6
Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming.癌症相关成纤维细胞的代谢重编程及其对癌细胞重编程的影响。
Theranostics. 2021 Jul 13;11(17):8322-8336. doi: 10.7150/thno.62378. eCollection 2021.
7
Metabolic Codependencies in the Tumor Microenvironment.肿瘤微环境中的代谢协同作用。
Cancer Discov. 2021 May;11(5):1067-1081. doi: 10.1158/2159-8290.CD-20-1211. Epub 2021 Jan 27.
8
Glutamine metabolism in breast cancer and possible therapeutic targets.乳腺癌中的谷氨酰胺代谢及潜在治疗靶点。
Biochem Pharmacol. 2023 Apr;210:115464. doi: 10.1016/j.bcp.2023.115464. Epub 2023 Feb 26.
9
Targeting amino acid metabolism in cancer.靶向癌症中的氨基酸代谢。
Int Rev Cell Mol Biol. 2022;373:37-79. doi: 10.1016/bs.ircmb.2022.08.001. Epub 2022 Sep 15.
10
Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment.肿瘤微环境中癌症相关成纤维细胞和免疫细胞的代谢重编程及串扰。
Front Endocrinol (Lausanne). 2022 Aug 15;13:988295. doi: 10.3389/fendo.2022.988295. eCollection 2022.

引用本文的文献

1
Methionine Dependency and Restriction in Cancer: Exploring the Pathogenic Function and Therapeutic Potential.癌症中的甲硫氨酸依赖性与限制:探索致病功能和治疗潜力
Pharmaceuticals (Basel). 2025 Apr 28;18(5):640. doi: 10.3390/ph18050640.
2
Dietary Fiber and Cancer Management: A Twenty-Five-Year Bibliometric Review of Research Trends and Directions.膳食纤维与癌症管理:对研究趋势和方向的25年文献计量学综述
Biomed Res Int. 2025 Apr 29;2025:5086946. doi: 10.1155/bmri/5086946. eCollection 2025.
3
Enhancing the Stability and Anticancer Activity of Asparaginase Through Nanoparticle Immobilization: A Biotechnological Perspective on Nano Chitosan.

本文引用的文献

1
Mitochondria-targeted nanoparticles (mitoNANO): An emerging therapeutic shortcut for cancer.线粒体靶向纳米颗粒(mitoNANO):一种新兴的癌症治疗捷径。
Biomater Biosyst. 2021 Aug 13;3:100023. doi: 10.1016/j.bbiosy.2021.100023. eCollection 2021 Sep.
2
Impact of particle size of multivesicular liposomes on the embolic and therapeutic effects in rabbit VX2 liver tumor.多泡脂质体粒径对兔 VX2 肝肿瘤栓塞和治疗效果的影响。
Drug Deliv. 2023 Dec;30(1):1-16. doi: 10.1080/10717544.2022.2157519.
3
Covalent Organic Frameworks as Nanocarriers for Improved Delivery of Chemotherapeutic Agents.
通过纳米颗粒固定化提高天冬酰胺酶的稳定性和抗癌活性:纳米壳聚糖的生物技术视角
Polymers (Basel). 2024 Nov 23;16(23):3260. doi: 10.3390/polym16233260.
4
PRODH Regulates Tamoxifen Resistance through Ferroptosis in Breast Cancer Cells.PRODH 通过铁死亡调控乳腺癌细胞对他莫昔芬的耐药性。
Genes (Basel). 2024 Oct 14;15(10):1316. doi: 10.3390/genes15101316.
5
The immune checkpoint TIGIT/CD155 promotes the exhaustion of CD8 + T cells in TNBC through glucose metabolic reprogramming mediated by PI3K/AKT/mTOR signaling.免疫检查点 TIGIT/CD155 通过 PI3K/AKT/mTOR 信号通路介导的葡萄糖代谢重编程促进三阴性乳腺癌中 CD8+T 细胞的衰竭。
Cell Commun Signal. 2024 Jan 12;22(1):35. doi: 10.1186/s12964-023-01455-z.
6
The Illustration of Altered Glucose Dependency in Drug-Resistant Cancer Cells.耐药癌细胞中葡萄糖依赖性改变的图示。
Int J Mol Sci. 2023 Sep 11;24(18):13928. doi: 10.3390/ijms241813928.
共价有机框架作为用于改善化疗药物递送的纳米载体
Materials (Basel). 2022 Oct 16;15(20):7215. doi: 10.3390/ma15207215.
4
TGM2-mediated histone transglutamination is dictated by steric accessibility.TGM2 介导的组蛋白谷氨酰胺转移酶反应受空间位阻控制。
Proc Natl Acad Sci U S A. 2022 Oct 25;119(43):e2208672119. doi: 10.1073/pnas.2208672119. Epub 2022 Oct 18.
5
Nanocarriers escaping from hyperacidified endo/lysosomes in cancer cells allow tumor-targeted intracellular delivery of antibodies to therapeutically inhibit c-MYC.纳米载体从癌细胞中过度酸化的内体/溶酶体逃逸,使抗体能够靶向肿瘤细胞内递送,从而抑制 c-MYC 的治疗作用。
Biomaterials. 2022 Sep;288:121748. doi: 10.1016/j.biomaterials.2022.121748. Epub 2022 Aug 19.
6
A randomized phase 3 trial of Gemcitabine or Nab-paclitaxel combined with cisPlatin as first-line treatment in patients with metastatic triple-negative breast cancer.一项吉西他滨或白蛋白紫杉醇联合顺铂作为转移性三阴性乳腺癌一线治疗的随机 3 期试验。
Nat Commun. 2022 Jul 12;13(1):4025. doi: 10.1038/s41467-022-31704-7.
7
Dual Inhibitions on Glucose/Glutamine Metabolisms for Nontoxic Pancreatic Cancer Therapy.双重抑制葡萄糖/谷氨酰胺代谢用于无毒胰腺癌治疗。
ACS Appl Mater Interfaces. 2022 May 18;14(19):21836-21847. doi: 10.1021/acsami.2c00111. Epub 2022 May 5.
8
Macropinocytosis and Cancer: From Tumor Stress to Signaling Pathways.巨胞饮作用与癌症:从肿瘤应激到信号通路。
Subcell Biochem. 2022;98:15-40. doi: 10.1007/978-3-030-94004-1_2.
9
Lactobacillus plantarum-derived metabolites sensitize the tumor-suppressive effects of butyrate by regulating the functional expression of SMCT1 in 5-FU-resistant colorectal cancer cells.植物乳杆菌衍生代谢物通过调节 5-FU 耐药结直肠癌细胞中 SMCT1 的功能表达来增强丁酸盐的抑瘤作用。
J Microbiol. 2022 Jan;60(1):100-117. doi: 10.1007/s12275-022-1533-1. Epub 2021 Dec 29.
10
Reuterin in the healthy gut microbiome suppresses colorectal cancer growth through altering redox balance.雷替曲塞在健康的肠道微生物群中通过改变氧化还原平衡抑制结直肠癌生长。
Cancer Cell. 2022 Feb 14;40(2):185-200.e6. doi: 10.1016/j.ccell.2021.12.001. Epub 2021 Dec 23.